Sentinel Lymph Node Biopsy Versus No Axillary Surgery in Early Breast Cancer

The VENUS trial is a prospective, multicenter, noninferiority, randomized, controlled clinical trial that compares sentinel lymph node biopsy versus no axillary surgery in women with early breast cancer (tumor \<5cm) and node-negative after clinical palpation and axillary ultrasound.

Trial Details

NCT ID
NCT05315154
Phase
NA
Sponsor
University of Campinas, Brazil
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • No axillary surgery
  • SLNB
Locations (sample)
  • Fortaleza, Ceará, Brazil|-3.71722,-38.54306
  • Goiânia, Goiás, Brazil|-16.67861,-49.25389
  • Goiânia, Goiás, Brazil|-16.67861,-49.25389
  • Belo Horizonte, Minas Gerais, Brazil|-19.92083,-43.93778
  • Muriaé, Minas Gerais, Brazil|-21.13056,-42.36639

Key Eligibility Criteria

  • Aged 18 years or older
  • Histologically confirmed invasive breast carcinoma (core or open biopsy), independent of hormone receptor and HER2 status
  • Tumor smaller than 5 cm (T1 or T2) in clinical and radiological exams
  • Clinically negative axilla

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →